Jaime Masjuan Vallejo-rekin lankidetzan egindako argitalpenak (26)

2021

  1. Time Trends in Intracerebral Hemorrhage Associated with Oral Anticoagulation and Its Risks Factors in Spain from 2008 to 2015

    European Neurology, Vol. 84, Núm. 1, pp. 16-21

2019

  1. The neurologist's approach to cerebral infarct and transient ischaemic attack in patients receiving anticoagulant treatment for non-valvular atrial fibrillation: ANITA-FA study

    European Journal of Neurology, Vol. 26, Núm. 2, pp. 230-237

2018

  1. Factors associated with poor anticoagulation control with vitamin K antagonists among outpatients attended in Internal Medicine and Neurology. The ALADIN study

    Revista Clinica Espanola, Vol. 218, Núm. 7, pp. 327-335

  2. Prognostic factors and analysis of mortality due to brain haemorrhages associated with vitamin K antagonist oral anticoagulants. Results from the TAC registry

    Neurologia, Vol. 33, Núm. 7, pp. 419-426

2017

  1. Clinical profile and satisfaction with anticoagulated treatment in patients with non-valvular atrial fibrillation attended in internal medicine and neurology departments of Spain

    Revista de Neurologia, Vol. 65, Núm. 8, pp. 361-367

2016

  1. Angina and future cardiovascular events in stable patients with coronary artery disease: Insights from the Reduction of Atherothrombosis for Continued Health (REACH) registry

    Journal of the American Heart Association, Vol. 5, Núm. 10

  2. Réplica a la carta «Algunas consideraciones sobre el infarto cerebral desde otra óptica»

    Neurologia

2014

  1. Clinical management guidelines for subarachnoid haemorrhage. Diagnosis and treatment

    Neurologia

  2. Guía para el tratamiento del infarto cerebral agudo

    Neurologia

  3. Guía para el tratamiento preventivo del ictus isquémico y AIT (II). Recomendaciones según subtipo etiológico

    Neurologia

  4. How predictors and patterns of stroke recurrence after a TIA differ during the first year of follow-up

    Journal of Neurology, Vol. 261, Núm. 8, pp. 1614-1621

2013

  1. Guías de actuación clínica en la hemorragia intracerebral

    Neurologia

  2. Recurrent transient ischaemic attack and early risk of stroke: Data from the PROMAPA study

    Journal of Neurology, Neurosurgery and Psychiatry, Vol. 84, Núm. 6, pp. 596-603

2012

  1. Benefits of intravenous thrombolysis in acute ischemic stroke related to extra cranial internal carotid dissection. Dream or reality?

    International Journal of Stroke, Vol. 7, Núm. 1, pp. 7-13

  2. Diabetes and previous stroke: Hazards for intravenous thrombolysis?

    European Journal of Neurology, Vol. 19, Núm. 4, pp. 587-593

  3. Efficacy of intravenous thrombolysis according to stroke subtypes: The Madrid Stroke Network data

    European Journal of Neurology, Vol. 19, Núm. 12, pp. 1568-1574

  4. Guía para el tratamiento preventivo del ictus isquémico y AIT (I). Actuación sobre los factores de riesgo y estilo de vida

    Neurologia

  5. Intravenous thrombolytic treatment in the oldest old

    Stroke Research and Treatment

  6. Prediction of early stroke recurrence in transient ischemic attack patients from the PROMAPA study: A comparison of prognostic risk scores

    Cerebrovascular Diseases, Vol. 33, Núm. 2, pp. 182-189

  7. Safety and outcomes following thrombolytic treatment in stroke patients who had received prior treatment with anticoagulants

    Cerebrovascular Diseases, Vol. 33, Núm. 3, pp. 231-239